Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person UniProt:Q9NQ25-2 SLAMF7

Class:IdReferenceIsoform:197841
_chainChangeLogsignal peptide:1-22 added on Fri February 6 2015;chain:23-335 added on Fri February 6 2015
_displayNameUniProt:Q9NQ25-2 SLAMF7
_timestamp2025-05-21 21:15:08
chainsignal peptide:1-22
chain:23-335
checksumD09ABBCFF74BE8D4
commentFUNCTION Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. Isoform 1 mediates NK cell activation through a SH2D1A-independent extracellular signal-regulated ERK-mediated pathway (PubMed:11698418). Positively regulates NK cell functions by a mechanism dependent on phosphorylated SH2D1B. Downstream signaling implicates PLCG1, PLCG2 and PI3K (PubMed:16339536). In addition to heterotypic NK cells-target cells interactions also homotypic interactions between NK cells may contribute to activation. However, in the absence of SH2D1B, inhibits NK cell function. Also acts inhibitory in T-cells (By similarity). May play a role in lymphocyte adhesion (PubMed:11802771). In LPS-activated monocytes negatively regulates production of pro-inflammatory cytokines (PubMed:23695528).FUNCTION Isoform 3 does not mediate any NK cell activation.SUBUNIT Isoform 1 binds to SH2D1A when its cytoplasmic tail is phosphorylated in the presence of FYN (in vitro); low affinity binding, the physiological relevance of the interaction is questioned. Interacts with SH2D1B; in NK cells (PubMed:16339536). Interacts (via ITSM phosphorylated on Tyr-302) with SH2D1B, PTPN6/SHP-1, PTPN11/SHP-2, INPP5D/SHIP1, CSK and FYN (By similarity).INTERACTION Expressed in spleen, lymph node, peripheral blood leukocytes, bone marrow, small intestine, stomach, appendix, lung and trachea. Expression was detected in NK cells, activated B-cells, NK-cell line but not in promyelocytic, B-, or T-cell lines. Expressed in monocytes. Isoform 3 is expressed at much lower level than isoform 1.DOMAIN The ITSMs (immunoreceptor tyrosine-based switch motifs) with the consensus sequence T-X-Y-X-X-[VI] present in SLAM family receptors have overlapping specificity for activating and inhibitory SH2 domain-containing binding partners. Especially they mediate the interaction with the SH2 domain of SH2D1A and SH2D1B. A 'three-pronged' mechanism is proposed involving threonine (position -2), phosphorylated tyrosine (position 0) and valine/isoleucine (position +3).MISCELLANEOUS Proposed to be involved in systemic lupus erythematosus (SLE) disease process.
created[InstanceEdit:197856] de Bono, B, 2007-05-15 13:53:41
descriptionrecommendedName: SLAM family member 7 alternativeName: CD2 subset 1 alternativeName: CD2-like receptor-activating cytotoxic cells shortName: CRACC alternativeName: Membrane protein FOAP-12 alternativeName: Novel Ly9 alternativeName: Protein 19A cdAntigenNameCD319/cdAntigenName
geneNameSLAMF7
CS1
UNQ576/PRO1138
identifierQ9NQ25
isoformParent
isSequenceChangedFALSE
keywordAdaptive immunity
Alternative splicing
Direct protein sequencing
Disulfide bond
Glycoprotein
Immunity
Immunoglobulin domain
Innate immunity
Membrane
Proteomics identification
Receptor
Reference proteome
Signal
Transmembrane
Transmembrane helix
modified[InstanceEdit:9836292] Weiser, Joel, 2023-05-25
[InstanceEdit:9852000] Weiser, Joel, 2023-11-03
[InstanceEdit:9926675] Weiser, Joel, 2024-11-03
[InstanceEdit:9948485] Weiser, Joel, 2025-05-21
nameSLAMF7
referenceDatabase[ReferenceDatabase:2] UniProt
referenceGene[ReferenceDNASequence:9004395] ENSEMBL:ENSG00000026751 SLAMF7 [Homo sapiens]
secondaryIdentifierSLAF7_HUMAN
A8K3U1
B4DPU4
B4DPY3
B4DWA3
Q8N6Y8
Q8ND32
Q9NY08
Q9NY23
sequenceLength335
species[Species:48887] Homo sapiens
variantIdentifierQ9NQ25-2
[Change default viewing format]
No pathways have been reviewed or authored by UniProt:Q9NQ25-2 SLAMF7 (197841)